Bortezomib-based treatment can improve factor X activity in immunoglobulin light-chain amyloidosis with factor X deficiency

Wu, X; Miao, HL; Zhu, TN; Feng, J; Zhang, L; Mao, YY; Zhou, DB; Cao, XX; Li, J

Cao, XX; Li, J (reprint author), Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Hematol, Beijing, Peoples R China.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019; 26 (4): 255